Gene therapy for haemophilia shows promise12th December 2011
A type of gene therapy to treat patients with haemophilia B could mean one injection would prevent them from having to take medication.
Researchers in the UK and the US gave six patients a virus which infected the body with the tools required to manufacture blood-clotting proteins.
Four of the six were able to stop taking medication. Doctors said the results of the trial could prove "life-changing" for patients.
Haemophilia B causes a fault in a person's genetic code which means they cannot produce a blood-clotting protein called factor IX.
The treatment for the condition is injections of factor IX, but it is expensive and time-consuming.
The researchers, from University College London and St Jude Children's Research Hospital, were investigating how to find a permanent fix for the condition.
Six participants were given a modified virus at the Royal Free Hospital in London. Two received a low dose, two a medium dose and two a high dose.
Haemophilia patients usually have factor IX levels at less than 1% of people who do not have the condition.
However, after they were injected with the virus the patients showed factor IX levels of between 2-12%.
Carl Walker, aged 26 and from Berkshire, showed the most impressive results following the treatment.
He said: "I have not needed any of my normal treatment, either preventative or on-demand as a result of an injury. Previously, I used to infuse at home three times a week."
"I play football, run and take part in triathlons - and previously I might have had to infuse both before I took part and possibly after as well. Not having to do that has been absolutely brilliant."
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Gene therapy for haemophilia shows promise
Author: Jess Laurence
Article Id: 20561
Date Added: 12th Dec 2011